Tower Research Capital LLC (Trc) Ocular Therapeutix, Inc Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,662 shares of OCUL stock, worth $64,376. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,662
Previous 36,297
84.4%
Holding current value
$64,376
Previous $336,000
80.36%
% of portfolio
0.0%
Previous 0.01%
Shares
33 transactions
Others Institutions Holding OCUL
# of Institutions
235Shares Held
157MCall Options Held
1.24MPut Options Held
423K-
Vr Adviser, LLC New York, NY13.2MShares$150 Million23.37% of portfolio
-
Summer Road LLC West Palm Beach, FL12.6MShares$143 Million98.91% of portfolio
-
Deep Track Capital, LP Greenwich, CT11.9MShares$136 Million4.4% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$131 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.3MShares$117 Million1.64% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $875M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...